A Randomized,Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Rifaximin for the Prevention of Travellers' Diarrhea
Phase of Trial: Phase III
Latest Information Update: 02 May 2017
At a glance
- Drugs Rifaximin (Primary)
- Indications Traveller's diarrhoea
- Focus Registrational; Therapeutic Use
- 11 Nov 2005 New trial record.